PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Although in vitro experiments suggested that PNPLA3 be involved in triglycerides metabolism [11,42], there was no association between I148M and triglycerides either in normal populations [11] or in our NAFLD cases (P–value > 0.10).